| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VRTX | Common Stock | Award | $0 | +1,168 | +29% | $0.000000 | 5,208 | 01 May 2023 | Direct | F1 |
| transaction | VRTX | Common Stock | Sale | $21,448 | -62 | -1.2% | $345.93 | 5,146 | 02 May 2023 | Direct | F2, F3, F4 |
| transaction | VRTX | Common Stock | Sale | $59,631 | -172 | -3.3% | $346.69 | 4,974 | 02 May 2023 | Direct | F2, F3, F5 |
| transaction | VRTX | Common Stock | Sale | $41,779 | -120 | -2.4% | $348.16 | 4,854 | 02 May 2023 | Direct | F2, F3, F6 |
| transaction | VRTX | Common Stock | Sale | $57,021 | -163 | -3.4% | $349.82 | 4,691 | 02 May 2023 | Direct | F2, F3, F7 |
| transaction | VRTX | Common Stock | Sale | $22,126 | -63 | -1.3% | $351.20 | 4,628 | 02 May 2023 | Direct | F2, F3, F8 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. |
| F2 | Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/17/2022. |
| F3 | Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| F4 | Open market sales reported on this line occurred at a weighted average price of $345.93 (range $345.20 to $346.12). |
| F5 | Open market sales reported on this line occurred at a weighted average price of $346.69 (range $346.31 to $347.03). |
| F6 | Open market sales reported on this line occurred at a weighted average price of $348.16 (range $347.91 to $348.64). |
| F7 | Open market sales reported on this line occurred at a weighted average price of $349.82 (range $349.17 to $350.08). |
| F8 | Open market sales reported on this line occurred at a weighted average price of $351.20 (range $350.92 to $351.48). |